Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
Clinical trial NCT02075008 · TERMINATED
Trial details
- NCT number
- NCT02075008
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-27
- Primary completion
- 2016-03-22
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.